Previous findings [20] showed that PD-L1 is at least partly glycosylated in cancer cells through the PD-L1 extracellular domain, and that the glycosylation of N192, N200, and N219 contributes to PD-L1 protein stability. This evidence concerns the gene CD274 and cancer.